Evidence map›Paper›PMID 41279154›Full record

ArticlebioRxiv : the preprint server for biology2025

Large field of view fluorescence imaging of microfluidic devices with a tandem-lens macroscope

Daniel A Mokhtari, Ali Lashkaripour, Polly M Fordyce

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Daniel A MokhtariVelocity Bio, Inc., 733 Industrial Rd, San Carlos, CA, USA.ORCID 0000-0003-4206-9471
Ali LashkaripourVelocity Bio, Inc., 733 Industrial Rd, San Carlos, CA, USA.ORCID 0000-0002-1734-9634
Polly M FordyceDepartment of Bioengineering, Stanford University, Stanford, CA, USA.ORCID 0000-0002-9505-0638

Funding

Using microfluidics to realize patient-specific anti-cancer immunotherapiesDP1CA290563 · NCI · STANFORD UNIVERSITY · PI Polly Morrell Fordyce · 2023 to 2026
$5.4M
NCI NIH HHS DP1 CA290563
6 · The paper itself

Abstract

Microfluidic devices enable high-throughput sample processing with remarkable parallelization and miniaturization. While fluorescence microscopy provides a convenient method for reading out signal from microfluidic assays, commercially-available microscopes impose a fundamental tradeoff between temporal resolution, spatial resolution, and numerical aperture (NA). Spatially tiled imaging enables high-resolution and high-NA imaging over a large area but reduces temporal resolution. Conversely, low magnification, low NA imaging captures large areas in one shot, but typically sacrifices spatial resolution and fluorescence sensitivity. To address this, we introduce an automated transfluorescence tandem-macro-lens optomechanical system (macroscope) capable of sensitive, multi-channel fluorescence imaging over a very large field of view (34 mm diameter, 740 mm

Identifiers

PMID41279154
PMCPMC12632801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.